Biological activity toxicity studies

Present research is devoted to investigation of application of luminol reactions in heterogeneous systems. Systems of rapid consecutive reactions usable for the determination of biologically active, toxic anions have been studied. Anions were quantitatively converted into chemiluminescing solid or gaseous products detectable on solid / liquid or gas / liquid interface. Methodology developed made it possible to combine concentration of microcomponents with chemiluminescence detection and to achieve high sensitivity of determination. 

Despite these biological activities, detailed study on the toxicology of brown algal fucoidan has been performed (Kim et al., 2010b). They have tested the toxicity of a 4-week oral trial of fucoidan extracted from the U. pinnatifida in Sprague-Dawley rats. 

In additional EPA studies, subchronic inhalation was evaluated ia the rat for 4 and 13 weeks, respectively, and no adverse effects other than nasal irritation were noted. In the above-mentioned NTP chronic toxicity study ia mice, no chronic toxic effects other than those resulting from bronchial irritation were noted. There was no treatment-related increase ia tumors ia male mice, but female mice had a slight increase in bronchial tumors. Neither species had an increase in cancer. Naphthalene showed no biological activity in other chemical carcinogen tests, indicating Htde cancer risk (44). No incidents of chronic effects have been reported as a result of industrial exposure to naphthalene (28,41). 

Rifamycia B is not biologically active but is spontaneously converted in aqueous solution to the active rifamycias O, S, and SV. Rifamycia SV was chosen for further studies because of its good in vivo activity, low toxicity, and solubiUty properties. Rifamycia SV is effective against a variety of infections as well as being active against tuberculosis and leprosy (168). Rifamycia P is the most active of the naturally occurring rifamycias (174). 

A Brief Review of the QSAR Technique. Most of the 2D QSAR methods employ graph theoretic indices to characterize molecular structures, which have been extensively studied by Radic, Kier, and Hall [see 23]. Although these structural indices represent different aspects of the molecular structures, their physicochemical meaning is unclear. The successful applications of these topological indices combined with MLR analysis have been summarized recently. Similarly, the ADAPT system employs topological indices as well as other structural parameters (e.g., steric and quantum mechanical parameters) coupled with MLR method for QSAR analysis [24]. It has been extensively applied to QSAR/QSPR studies in analytical chemistry, toxicity analysis, and other biological activity prediction. On the other hand, parameters derived from various experiments through chemometric methods have also been used in the study of peptide QSAR, where partial least-squares (PLS) analysis has been employed [25]. 

Previous syntheses An example of this point can be recognized by examination of one known synthesis of thienobenzazepines (Scheme 6.1). This synthetic route involves a key palladinm-catalyzed cross-conpling of stannyl intermediate 3, prepared by method of Gronowitz et al., with 2-nitrobenzyl bromide. Acetal deprotection and reductive cyclization afforded the desired thienobenzazepine tricycle 4. In support of structure activity relationship studies, this intermediate was conveniently acylated with varions acyl chlorides to yield several biologically active componnds of structure type 5. While this synthetic approach does access intermediate 4 in relatively few synthetic transformations for stractnre activity relationship studies, this route is seemingly nnattractive for preparative scale requiring stoichiometric amounts of potentially toxic metals that are generally difficult to remove and present costly purification problems at the end of the synthesis. 

The district court then turned its attention to an article entitled "Studies on Antidiabetic Agents, II. Synthesis of 5-[4-(l-Methylcyclohexylmethoxy)-benzyl]thiazoli-dine-2,4-dione (ADD-3878) and Its Derivatives" (the Sodha II reference). Sodha II, while disclosing compound (2), also identified three specific compounds that displayed the most favorable combination of toxicity, decreased side effects, and good biological activity—compound (2) was not one of the three favored compounds [35]. 

In phase I clinical trials 47 patients, all of whom had previously failed standard treatments for solid tumors, received the drug in the UK, Italy, and Switzerland on three different schedules.123,124 Dose-limiting toxicities have been defined as bone marrow depression and diarrhea. The latter is treatable with loperamide. Signs of biological activity were seen. Notably one patient with metastatic pancreatic cancer showed a partial response (for 4 months) and two further patients, one with metastatic melanoma and one with bronchoalveolar carcinoma, also showed partial responses. In a phase I trial in combination with 5-FU, a partial response in breast cancer was observed.125 Furthermore, a reduction in tumor marker levels was observed in two patients, one with ovarian cancer, and one with colon cancer. Phase II studies have shown partial responses in cisplatin-resistant ovarian and nonsmall-cell lung cancer.126,127 The indications are that the profile of clinical activity is different and complementary to the mononuclear platinum agents. 

The provocative initial biological activities reported for PatA, primarily the 20,000-fold difference in toxicity toward cancer cells (P388) versus a quiescent cell line (BSC) (Northcote et al, 1991), led us to undertake a total synthesis of this natural product that would ultimately enable detailed mode of action studies. We envisioned the synthesis and subsequent union of three principal fragments, namely, enyne acid 4, /1-lactam 10, and dienylstannane 14 (Fig. 14.1). A crucial aspect of this plan was a late-stage Stille coupling to append the expected labile trienyl... 

A review article has appeared (237) which discusses the biological activity of thioethers and their derivatives with particular reference to interactions with transition-metal ions. Accordingly, only some of the more salient points will be discussed here. In any biological studies, the toxicity of Me2SO 482) and of its transition-metal complexes 140) should be borne in mind. 

The preclinical knowledge base is initially developed by designing studies to answer fundamental questions. The development of this knowledge base is generally applicable to most pharmaceuticals as well as biopharmaceuticals, and include data to support (1) the relationship of the dose to the biological activity, (2) the relationship of the dose to the toxicity, (3) the effect of route and/or schedule on activity or toxicity and (4) identification of the potential risks for subsequent clinical studies. These questions are considered in the context of indication and/or disease state. In addition there are often unique concerns related to the specific category or product class. 

Traditionally, the duration of a toxicity study depends on the intended clinical use and disease duration. The potential immunogenicity of the human protein is a significant issue since antibody binding can partially or completely inhibit the biological activity of that protein, affect its catabolism or alter its distribution and clearance. Any multiple-dose study therefore should include evaluation of the impact of antibody formation, including their neutralizing capacity. However, antibody formation in itself should not be a reason for termination of a toxicity study, particularly if the antibodies are not neutralizing or do not alter the pharmacodynamics of the protein. 

---